Eliprodil

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEliprodil
Drug Alias Nameeliprodilum依利罗地eliprodilSL-82.0715SL-820715
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsMovement DisordersStrokeBrain Injuries +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiNational Institute Of Neurological Disorders And Stroke
Active IndicationsN/A
Inactive IndicationsMovement DisordersStrokeBrain Injuries +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia